Contents
Academy · Research Writing · PRO
Patient-Reported Outcome (PRO): Definition, Instrument Validity and Missing Data
A patient-reported outcome (PRO) is defined by the source of the report rather than by the construct measured. Once a clinician interprets or adjusts a patient’s response, the measure no longer qualifies as a PRO.
A Patient-Reported Outcome (PRO) is any report of the status of a patient's health condition that comes directly from the patient, without interpretation by a clinician or anyone else, as defined in the FDA's PRO guidance for industry.
Learning objectives
- The criteria that distinguish a PRO from a clinician-reported or observer-reported outcome measure.
- The reasons a validated PRO instrument cannot be modified informally without revalidation.
- The effect of unplanned missing PRO data on the interpretability of a trial.
Common misconceptions
- “Any outcome related to how a patient feels counts as a PRO, even if a clinician records their impression of it.” FDA's PRO guidance specifically requires the report to come directly from the patient, without interpretation by a clinician, caregiver or anyone else — a clinician's assessment of how a patient seems to be feeling is a clinician-reported outcome, not a PRO, even though both concern the patient's subjective state.
Defining characteristics of a PRO
FDA's guidance for industry on patient-reported outcome measures defines a PRO as any report of the status of a patient's health condition that comes directly from the patient, without interpretation of the patient's response by a clinician or anyone else1. This directness is the defining feature: the same underlying symptom, reported by the patient versus assessed by a clinician observing the patient, constitutes a PRO in the first case and a clinician-reported outcome in the second.
Constraints on modifying a validated PRO instrument
PRO instruments used to support a specific labelling claim are typically validated for that specific context of use — the population, the condition, and the concept measured. FDA's guidance treats informal modification of a validated instrument's wording, response options or administration mode as potentially invalidating the instrument for that use, since validation evidence was generated for the instrument as originally structured, not an altered version of it.
Effect of missing PRO data on interpretability
Because PRO data can only come directly from the patient, missing responses (from dropout, missed visits or incomplete questionnaires) cannot be completed by a clinician’s judgement without changing what is being measured. A trial using a PRO as a key outcome requires a pre-specified plan for handling missing PRO data, since informal imputation risks reintroducing precisely the interpretive layer that the PRO was designed to avoid.
Key points
Key points
A PRO is defined by its coming directly from the patient without interpretation, which is why a validated PRO instrument cannot be informally modified, and why missing PRO data require a pre-specified handling plan rather than clinician-judged imputation.
Practical application
Practical application
- Investigators should confirm that the outcome is genuinely patient-reported rather than clinician-assessed. The response should come directly from the patient, without an added layer of clinician interpretation.
- PRO instruments should be used exactly as validated, without informal modification. The wording, response options or administration mode of a validated instrument should not be altered without revalidation.
- The handling of missing PRO data should be pre-specified. The missing-data approach for PRO outcomes should be defined in the statistical analysis plan (SAP) before data collection begins.
Frequently asked questions
Only if the patient completes it directly without a clinician's interpretation; a clinician-administered quality-of-life assessment based on their own judgement of the patient is a different outcome category.
Not informally — shortening or otherwise modifying a validated instrument generally requires new validation evidence for the modified version before it can be relied upon for the same purpose.
References
- U.S. Food and Drug Administration (FDA). Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims, Guidance for Industry. read 10 October 2026. View FDA Guidance
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 10). Patient-Reported Outcome (PRO): Definition, Instrument Validity and Missing Data. Pubrica. https://pubrica.com/academy/abbreviations/pro-patient-reported-outcome/
Pubrica Academy. “Patient-Reported Outcome (PRO): Definition, Instrument Validity and Missing Data.” Pubrica, 10 Oct. 2026, pubrica.com/academy/abbreviations/pro-patient-reported-outcome/.
Pubrica Academy (2026) Patient-Reported Outcome (PRO): Definition, Instrument Validity and Missing Data. Pubrica. Available at: https://pubrica.com/academy/abbreviations/pro-patient-reported-outcome/ (Accessed: 15 October 2026).
Pubrica Academy. “Patient-Reported Outcome (PRO): Definition, Instrument Validity and Missing Data.” Pubrica. October 10, 2026. https://pubrica.com/academy/abbreviations/pro-patient-reported-outcome/
Pubrica Academy, ‘Patient-Reported Outcome (PRO): Definition, Instrument Validity and Missing Data’ (Pubrica, 10 October 2026) <https://pubrica.com/academy/abbreviations/pro-patient-reported-outcome/> accessed 15 October 2026.
Pubrica Academy. Patient-Reported Outcome (PRO): Definition, Instrument Validity and Missing Data. [Internet]. Pubrica; 2026 Oct 10 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/abbreviations/pro-patient-reported-outcome/
Pubrica Academy, “Patient-Reported Outcome (PRO): Definition, Instrument Validity and Missing Data,” Pubrica, Oct. 10, 2026. [Online]. Available: https://pubrica.com/academy/abbreviations/pro-patient-reported-outcome/
@misc{pro_patient_reported_outcome_2026,
author = {{Pubrica Academy}},
{k:"article",c:"writing",t:"Influence of Journal Submission Strategies on Authors and Open Research",d:"A verified look at how journal submission-stage policies, including open-data badges, have measurably changed author behavior, with practical guidance on checking a target journal\'s requirements before you submit.",s:"Pubrica Academy",st:"ready",u:"/academy/concepts-definitions/the-influence-of-journal-submission-strategies-on-authors-and-use-of-open-research-journals/",sv:"",sb:"",ta:"",in:"research",tp:"w-concept",dt:"2026-10-10",mn:7,au:"Pubrica Academy",kw:"open science|journal policy|data sharing|open data badges"},
{k:"article",c:"data",t:"Submission and Citation Study on Temporal Variation of Journal Impact Factor",d:"A verified look at documented cases of journal impact-factor volatility, including denominator reclassification and citation stacking, with practical guidance on reading the metric responsibly.",s:"Pubrica Academy",st:"ready",u:"/academy/concepts-definitions/submission-and-citation-based-study-on-temporal-variation-of-journal-impact-factor/",sv:"",sb:"",ta:"",in:"research",tp:"w-concept",dt:"2026-10-10",mn:7,au:"Pubrica Academy",kw:"impact factor|bibliometrics|citation analysis|journal metrics"},
{k:"article",c:"publication",t:"Journal Manuscript Submission and Review During the COVID-19 Pandemic",d:"A verified look at two major studies of manuscript submission and peer review during COVID-19, covering ecology journals and a general medical journal, with practical guidance for authors.",s:"Pubrica Academy",st:"ready",u:"/academy/concepts-definitions/during-the-covid-19-pandemic-journal-manuscript-submission-and-review/",sv:"",sb:"",ta:"",in:"research",tp:"w-concept",dt:"2026-10-10",mn:7,au:"Pubrica Academy",kw:"peer review|COVID-19|submission volume|editorial process"},
{k:"article",c:"writing",t:"Criteria to Consider When Selecting a Journal for Publication",d:"A verified, checklist-based guide to the criteria for selecting a journal for publication, covering scope, metrics, indexing, peer-review quality, ethics policies, and practical costs.",s:"Pubrica Academy",st:"ready",u:"/academy/concepts-definitions/criteria-to-consider-when-selecting-a-journal-for-publication/",sv:"",sb:"",ta:"",in:"research",tp:"w-checklist",dt:"2026-10-10",mn:8,au:"Pubrica Academy",kw:"journal selection|peer review|publication ethics|COPE"},
{k:"article",c:"writing",t:"Investigating Journal Selection Decisions: A Survey of Academic Researchers",d:"A verified look at a large survey of academic researchers\' journal-selection priorities, covering sample size, methodology, and the top-ranked factors across career stages and disciplines.",s:"Pubrica Academy",st:"ready",u:"/academy/concepts-definitions/investigating-journal-selection-decisions-a-survey-of-academic-researchers/",sv:"",sb:"",ta:"",in:"research",tp:"w-concept",dt:"2026-10-10",mn:7,au:"Pubrica Academy",kw:"journal selection|researcher survey|peer review|publication strategy"},
{k:"article",c:"publication",t:"Evaluating Niche and Field-Specific Journals in a Journal-Selection Strategy",d:"How to evaluate a niche or field-specific journal before submitting: scope match, DOAJ-style indexing checks, editorial board credibility, and documented predatory-journal warning signs.",s:"DOAJ; Think.Check.Submit.; Shamseer et al., BMC Medicine 2017",st:"ready",u:"/academy/concepts-definitions/academy-of-strategic-management-of-journal-selection/",sv:"",sb:"",ta:"",in:"research",tp:"w-journal-selection",dt:"2026-10-10",mn:7,au:"Pubrica Academy",kw:"journal selection|niche journal|predatory journal|DOAJ"},
{k:"article",c:"publication",t:"Journal Selection and Evaluation Systems Analysis",d:"A comparison of the Journal Impact Factor (Clarivate JCR), CiteScore (Scopus), SCImago Journal Rank (SJR), and DOAJ listing, plus documented predatory-journal warning signs.",s:"Clarivate; Elsevier; SCImago; DOAJ; Think.Check.Submit.; Shamseer et al., BMC Medicine 2017",st:"ready",u:"/academy/concepts-definitions/a-comprehensive-analysis-of-the-journal-selection-and-evaluation-systems/",sv:"",sb:"",ta:"",in:"research",tp:"w-journal-metrics",dt:"2026-10-10",mn:8,au:"Pubrica Academy",kw:"impact factor|citescore|SJR|DOAJ|predatory journal"},
{k:"article",c:"writing",t:"Power Relations in Scientific Communication: What Health-Literacy Research Shows",d:"What a systematic review of health literacy and clinical-trial informed consent shows about the gap between how research materials are written and what patients understand.",s:"Burks & Keim-Malpass, Nursing: Research and Reviews 2019",st:"ready",u:"/academy/scientific-communication/power-relations-in-educational-scientific-communication-a-critical-examination-of-learning-style-discourse/",sv:"",sb:"",ta:"",in:"research",tp:"w-sci-comm",dt:"2026-10-10",mn:7,au:"Pubrica Academy",kw:"health literacy|informed consent|science communication|plain language"},
{k:"article",c:"writing",t:"Accuracy of Abstracts in Pharmacy Journals for Original Research Articles",d:"What two direct studies found when they checked research-article abstracts against their own full text, including documented inaccuracy rates in pharmacy journals.",s:"Ward, Kendrach & Price, Ann Pharmacother 2004; Fontelo et al., Evid Based Med 2013",st:"ready",u:"/academy/research-article/accuracy-of-abstracts-in-pharmacy-journals-for-original-research-articles/",sv:"",sb:"",ta:"",in:"research",tp:"w-abstract-accuracy",dt:"2026-10-10",mn:6,au:"Pubrica Academy",kw:"abstract accuracy|pharmacy journals|research writing|manuscript quality"},
{k:"article",c:"writing",t:"Developing a Narrative Literature Review for an Academic Research Thesis",d:"A practical guide to developing a narrative literature review for an academic thesis, based on the step-by-step model of defining, searching, appraising and synthesising the literature.",s:"Cronin, Ryan & Coughlan, British Journal of Nursing (2008)",st:"ready",u:"/academy/concepts-definitions/a-narrative-literature-review-development-for-an-academic-research-thesis/",sv:"",sb:"",ta:"",in:"research",tp:"w-literature-review",dt:"2026-10-10",mn:7,au:"Pubrica Academy",kw:"literature review|thesis writing|narrative review methodology"},
{k:"article",c:"data",t:"Translational Research Ecosystems: What Drives Academia-Industry Biomedical Innovation",d:"An explainer on translational research ecosystems, the academia-industry valley of death, and how institutional bridges move biomedical discoveries toward application.",s:"Mahant, Journal of Translational Medicine (2020)",st:"ready",u:"/academy/concepts-definitions/a-comprehensive-assessment-of-the-literature-on-entrepreneurial-ecosystems-in-advanced-and-emerging-economies/",sv:"",sb:"",ta:"",in:"research",tp:"d-translational-ecosystem",dt:"2026-10-10",mn:7,au:"Pubrica Academy",kw:"translational research|academia industry collaboration|biomedical innovation"},
{k:"article",c:"writing",t:"Systematic Literature Reviews in Health Services and Management Research",d:"How to apply a three-stage systematic review methodology, adapted from management research, to health services and health-system management questions.",s:"Tranfield, Denyer & Smart, British Journal of Management (2003)",st:"ready",u:"/academy/concepts-definitions/additional-advantages-and-execution-processes-from-a-systematic-literature-analysis-in-management-research/",sv:"",sb:"",ta:"",in:"research",tp:"w-systematic-review-management",dt:"2026-10-10",mn:7,au:"Pubrica Academy",kw:"systematic literature review|health services management|evidence-informed management"},
{k:"article",c:"data",t:"Mapping the Pandemic-Era Medical Supply Chain Literature: A Structured Review",d:"A review of how pandemic-era pharmaceutical supply chain disruption has been studied, based on a PRISMA-guided scoping review identifying three drivers of disruption.",s:"Ferdous et al., Australasian Journal of Regional Studies (2023)",st:"ready",u:"/academy/concepts-definitions/a-structured-literature-review-and-bibliometric-network-analysis-of-pandemic-supply-chain-research/",sv:"",sb:"",ta:"",in:"research",tp:"d-pandemic-supply-chain",dt:"2026-10-10",mn:6,au:"Pubrica Academy",kw:"pandemic supply chain|pharmaceutical supply chain|scoping review methodology"},
title = {Patient-Reported Outcome (PRO): Definition, Instrument Validity and Missing Data},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/abbreviations/pro-patient-reported-outcome/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
PRO instrument check
Intended for use when selecting and implementing a PRO measure.
[ ] Outcome confirmed as genuinely patient-reported, not clinician-interpreted [ ] Instrument used exactly as validated, without informal modification [ ] Missing-data handling for PRO data pre-specified in the SAP [ ] Context of use (population, condition, concept) matches the instrument's validation evidence
Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica assists in selecting and correctly implementing validated PRO instruments appropriate to the specific context of use, with a pre-specified missing-data plan.